PROCEPT BioRobotics CorporationPRCT stock score: 51/100

$25.75 · +2.26% · Scored Nov 19, 2026

Technical
52
Fundamental
50
News
—

The reading

PROCEPT BioRobotics (PRCT) scores 51 out of 100, which reads neutral, higher than 50% of Healthcare stocks and 47% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 50, technicals 52.

Among the fundamentals, Revenue Growth (5-Year) at 100 and Quick Ratio at 99 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 72 and contrarian oscillators 29 — a split worth reading before trusting the technical total.

Since Aug 22, 2026 the composite has ranged from 34 to 51, and it is up 11 points over the period.

About PROCEPT BioRobotics

PROCEPT BioRobotics (PRCT) is a U.S. surgical robotics company that develops systems for treating benign prostatic hyperplasia, the noncancerous enlargement of the prostate that causes urinary symptoms in many older men. Its HYDROS and earlier AquaBeam robotic systems deliver Aquablation therapy, which uses a heat-free waterjet guided by real-time ultrasound imaging to remove prostate tissue according to a surgeon’s plan, with HYDROS adding artificial intelligence to help with treatment planning. The approach is designed to treat prostates of many sizes and shapes while preserving functions that other surgeries can affect. Customers are hospitals and urologists in the United States, with international expansion starting in the United Kingdom. PROCEPT earns money from selling robotic systems, from single-use handpieces and other consumables used in every procedure and from service contracts, so recurring revenue grows as procedure volumes rise.

PROCEPT competes with traditional prostate surgery such as transurethral resection, with laser procedures and with less invasive treatments such as Boston Scientific’s Rezum and UroLift. Its edge rests on a robotic, image-guided procedure supported by a growing body of clinical studies, a guideline recommendation from European urologists and an installed base of systems that drives consumable sales. Investors who follow PRCT stock tend to watch system placements, procedure volumes and handpiece revenue. Utilization of installed systems and surgeon training are closely followed. Reimbursement rates, international expansion, gross margins, operating losses and cash use are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward PRCT’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

50

Pulling it up

  • 5-year revenue growth analyzes long-term sales trajectory and consistency.

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

  • Operating margins measure profitability after operating expenses.

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

64

Pulling it up

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • TRIX100

    TRIX is a triple-smoothed momentum oscillator.

  • VWAP100

    Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

Holding it back

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical score by timeframe

ChartScoreWeight
Hourly561
Daily643
Weekly442
Monthly392

Composite score, last 90 days

05010051Aug 22, 2026Nov 19, 2026Aug 22, 2026: 40Aug 23, 2026: 39Aug 24, 2026: 38Aug 25, 2026: 39Aug 26, 2026: 38Aug 27, 2026: 36Aug 28, 2026: 36Aug 29, 2026: 37Aug 30, 2026: 37Aug 31, 2026: 37Sep 1, 2026: 38Sep 2, 2026: 40Sep 3, 2026: 39Sep 4, 2026: 40Sep 5, 2026: 40Sep 6, 2026: 40Sep 7, 2026: 41Sep 8, 2026: 38Sep 9, 2026: 36Sep 10, 2026: 35Sep 11, 2026: 36Sep 12, 2026: 36Sep 13, 2026: 36Sep 14, 2026: 37Sep 15, 2026: 35Sep 16, 2026: 35Sep 17, 2026: 35Sep 18, 2026: 36Sep 19, 2026: 35Sep 20, 2026: 35Sep 21, 2026: 35Sep 22, 2026: 35Sep 23, 2026: 36Sep 24, 2026: 35Sep 25, 2026: 34Sep 26, 2026: 35Sep 27, 2026: 35Sep 28, 2026: 35Sep 29, 2026: 36Sep 30, 2026: 36Oct 1, 2026: 35Oct 2, 2026: 35Oct 3, 2026: 35Oct 4, 2026: 35Oct 5, 2026: 36Oct 6, 2026: 36Oct 7, 2026: 37Oct 8, 2026: 37Oct 9, 2026: 38Oct 10, 2026: 38Oct 11, 2026: 38Oct 12, 2026: 39Oct 13, 2026: 38Oct 14, 2026: 35Oct 15, 2026: 36Oct 16, 2026: 35Oct 17, 2026: 35Oct 18, 2026: 35Oct 19, 2026: 37Oct 20, 2026: 38Oct 21, 2026: 38Oct 22, 2026: 40Oct 23, 2026: 40Oct 24, 2026: 40Oct 25, 2026: 40Oct 26, 2026: 40Oct 27, 2026: 39Oct 28, 2026: 41Oct 29, 2026: 40Oct 30, 2026: 38Oct 31, 2026: 38Nov 1, 2026: 38Nov 2, 2026: 38Nov 3, 2026: 40Nov 4, 2026: 40Nov 5, 2026: 41Nov 6, 2026: 40Nov 7, 2026: 40Nov 8, 2026: 40Nov 10, 2026: 43Nov 11, 2026: 43Nov 12, 2026: 50Nov 13, 2026: 51Nov 14, 2026: 51Nov 15, 2026: 51Nov 16, 2026: 51Nov 17, 2026: 51Nov 18, 2026: 51Nov 19, 2026: 51
Show the daily numbers
DateComposite
Nov 19, 202651
Nov 18, 202651
Nov 17, 202651
Nov 16, 202651
Nov 15, 202651
Nov 14, 202651
Nov 13, 202651
Nov 12, 202650
Nov 11, 202643
Nov 10, 202643
Nov 8, 202640
Nov 7, 202640
Nov 6, 202640
Nov 5, 202641
Nov 4, 202640
Nov 3, 202640
Nov 2, 202638
Nov 1, 202638
Oct 31, 202638
Oct 30, 202638
Oct 29, 202640
Oct 28, 202641
Oct 27, 202639
Oct 26, 202640
Oct 25, 202640
Oct 24, 202640
Oct 23, 202640
Oct 22, 202640
Oct 21, 202638
Oct 20, 202638
Oct 19, 202637
Oct 18, 202635
Oct 17, 202635
Oct 16, 202635
Oct 15, 202636
Oct 14, 202635
Oct 13, 202638
Oct 12, 202639
Oct 11, 202638
Oct 10, 202638
Oct 9, 202638
Oct 8, 202637
Oct 7, 202637
Oct 6, 202636
Oct 5, 202636
Oct 4, 202635
Oct 3, 202635
Oct 2, 202635
Oct 1, 202635
Sep 30, 202636
Sep 29, 202636
Sep 28, 202635
Sep 27, 202635
Sep 26, 202635
Sep 25, 202634
Sep 24, 202635
Sep 23, 202636
Sep 22, 202635
Sep 21, 202635
Sep 20, 202635
Sep 19, 202635
Sep 18, 202636
Sep 17, 202635
Sep 16, 202635
Sep 15, 202635
Sep 14, 202637
Sep 13, 202636
Sep 12, 202636
Sep 11, 202636
Sep 10, 202635
Sep 9, 202636
Sep 8, 202638
Sep 7, 202641
Sep 6, 202640
Sep 5, 202640
Sep 4, 202640
Sep 3, 202639
Sep 2, 202640
Sep 1, 202638
Aug 31, 202637
Aug 30, 202637
Aug 29, 202637
Aug 28, 202636
Aug 27, 202636
Aug 26, 202638
Aug 25, 202639
Aug 24, 202638
Aug 23, 202639
Aug 22, 202640

Key facts

Market cap
$1.5B
Sector
Healthcare
Industry
Medical Devices
Beta
0.84
Risk grade (1–10)
9
Next earnings
Nov 4, 2026

Questions

What is PRCT's stock rating today?

PRCT scores 51/100 (Neutral) as of Nov 19, 2026: technical 52, fundamental 50. Scores are recomputed every night.

What does PROCEPT BioRobotics do?

PROCEPT BioRobotics (PRCT) is a U.S. surgical robotics company that develops systems for treating benign prostatic hyperplasia, the noncancerous enlargement of the prostate that causes urinary symptoms in many older men.

Is PRCT stock a buy?

The score is not a buy or sell recommendation. A 51 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the PRCT score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

PRCT stock score

HTML

<a href="https://stocksscores.com/stocks/prct/"><img src="https://stocksscores.com/stocks/prct/badge.svg" alt="PRCT stock score" height="20"></a>

Markdown

[![PRCT stock score](https://stocksscores.com/stocks/prct/badge.svg)](https://stocksscores.com/stocks/prct/)